Global X China Biotech ETF
Global X China Biotech ETF (HK:2820) Price & Chart
HK:2820 ETF Chart & Stats
- Day’s Range
- HKD 69.68 - HKD 70.88
- 52-Week Range
- HKD 56.70 - HKD 80.00
- Previous Close
- HKD 71.64
- Volume
- 16.40K
- Average Volume (3M)
- 16.29K
- AUM
- 673.02M
- NAV
- 71.50
- Expense Ratio
- 0.68%
- Holdings Count
- 0
- Beta
- 0.75
- Inception Date
- Jul 25, 2019
- Last Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
- Shares Outstanding
- 9,500,000
- Standard Deviation
- N/A
ETF Overview
Global X China Biotech ETF
The Global X China Biotech ETF (Ticker: HK:2820) offers investors a unique gateway into China's burgeoning biotechnology sector, a critical segment of the healthcare industry. This ETF is meticulously designed to capture the growth potential of Chinese biotech companies, which are at the forefront of innovation in medical treatments, pharmaceuticals, and cutting-edge biotechnological advancements. As a sector-focused fund, it zeroes in on health care, specifically tailored to biotechnology, providing exposure to companies that are pioneering in areas such as genetic engineering, molecular biology, and drug discovery. Investors interested in capitalizing on the rapid advancements and increasing global significance of China's biotech industry will find this ETF to be a compelling choice. With China's commitment to healthcare reform and investment in biotech research and development, the Global X China Biotech ETF represents a strategic investment in a niche poised for dynamic growth and transformation.
- Asset Class
- Equity
- Region
- Asia-Pacific
- Issuer
- Global X
- Index Tracked
- Solactive China Biotech Index
- Ticker Symbol
- HK:2820

